Skip to Main Content

Paper Details

Clinical outcomes of switching to aflibercept using a pro re nata treatment regimen in patients with neovascular age-related macular degeneration who incompletely responded to ranibizumab.
BMC Ophthalmol
2
2018
Author NameAffiliation
Shyamanga Borooah
Shyamanga BorooahCollege of Medicine & Veterinary Medicine, University of Edinburgh
  • 1 - 2

Datasets

Release 1.2